backJoin us for our fifth CLE webinar in the Fundamentals of EU Pharmaceutical Law series; it will focus on the complex and evolving landscape of combination, personalized and advanced therapy medicinal products.
These innovative categories of products present unique regulatory challenges either because of the parallel application of different legal regimes or because of their novel and complex nature. Topics include the regulatory requirements for conducting combined clinical trials, the additional and specific approval requirements, the outstanding issues faced by those products, and the potential impact of the upcoming revision of the EU general pharmaceutical legislation.
Do not miss this opportunity to gain a deeper understanding of the fundamental regulatory landscape shaping the future of pharmaceutical innovation in the EU.
For questions, contact Christine Lieber.